List all clinical trials by discovery date. Accepts regular expressions in search.

GET /trials/
HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 814,
    "next": "http://api.gregory-ms.com/trials/?page=2",
    "previous": null,
    "results": [
        {
            "trial_id": 538542,
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "summary": "<p>EudraCT Number: 2006-002982-38<br />Sponsor Protocol Number: 27025<br />Sponsor Name: Merck Serono S.A.-Geneva, an affiliate of Merck KGaA Darmstadt, Germany<br />Start Date: 2006-11-29<br />Medical condition: Subjects at high risk of converting to Multiple Sclerosis<br />Disease: <br />Version: 9.0<br />SOC Term: <br />Classification Code: 10028245<br />Term: <br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/BE\">BE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/CZ\">CZ</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/AT\">AT</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/LT\">LT</a> (Prematurely Ended), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/SK\">SK</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/DE\">DE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/FI\">FI</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/FR\">FR</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/EE\">EE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/DK\">DK</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/IT\">IT</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/GR\">GR</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/PT\">PT</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/ES\">ES</a> (Completed)</p>",
            "published_date": null,
            "discovery_date": "2023-06-08T11:10:42.583956Z",
            "link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number%3A2006-002982-38",
            "source": "European Clinical Trials Register",
            "relevant": null,
            "identifiers": {
                "nct": null,
                "euct": "2006-002982-38",
                "eudract": "2006-002982-38"
            },
            "categories": []
        },
        {
            "trial_id": 538435,
            "title": "Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Primary Progressive Multiple Sclerosis;   Secondary-progressive Multiple Sclerosis<br /><b>Interventions</b>:    Drug: Metformin Hydrochloride 850 mg Oral Tablet;   Drug: Placebo<br /><b>Sponsors</b>:    University Hospital, Antwerp;   University Hospital, Ghent;   Hasselt University;   AZ Sint-Jan AV;   Noorderhart Pelt;   National MS Center Melsbroek<br /><b>Not yet recruiting</b>",
            "published_date": "2023-06-07T16:00:00Z",
            "discovery_date": "2023-06-07T12:50:42.279113Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05893225?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null,
            "identifiers": {
                "nct": "NCT05893225",
                "euct": null,
                "eudract": null
            },
            "categories": [
                {
                    "category_id": 6,
                    "category_description": "",
                    "category_name": "Metformin",
                    "category_slug": "metformin",
                    "category_terms": [
                        "metformin"
                    ]
                }
            ]
        },
        {
            "trial_id": 538285,
            "title": "MS Fatigue and tDCS on Fatigue in Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Fatigue in Multiple Sclerosis<br /><b>Interventions</b>:    Procedure: Real left prefrontal tDCS - sham;   Procedure: Sham - Real left prefrontal tDCS<br /><b>Sponsor</b>:    Assistance Publique - Hôpitaux de Paris<br /><b>Recruiting</b>",
            "published_date": "2023-06-06T16:00:00Z",
            "discovery_date": "2023-06-06T12:50:42.940754Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05890885?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null,
            "identifiers": {
                "nct": "NCT05890885",
                "euct": null,
                "eudract": null
            },
            "categories": []
        },
        {
            "trial_id": 538128,
            "title": "Examining a Wheelchair Exercise-training Intervention for Persons With Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Interventions</b>:    Behavioral: Seated Physical activity INtervention for persons with MS, \"SPIN\" program- Intervention Condition;   Behavioral: Wellness for MS (WellMS)- Control Condition<br /><b>Sponsors</b>:    University of North Texas, Denton, TX;   University of Illinois at Chicago;   Craig Hospital;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)<br /><b>Not yet recruiting</b>",
            "published_date": "2023-06-05T16:00:00Z",
            "discovery_date": "2023-06-05T13:30:45.596685Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05888727?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null,
            "identifiers": {
                "nct": "NCT05888727",
                "euct": null,
                "eudract": null
            },
            "categories": []
        },
        {
            "trial_id": 538100,
            "title": "An open-label, multicenter, biomarker study to explore the mechanism of action of ocrelizumab and B-cell biology in patients with relapsing multiple sclerosis or primary progressive multiple sclero...",
            "summary": "<p>EudraCT Number: 2015-004616-37<br />Sponsor Protocol Number: ML29966<br />Sponsor Name: GENENTECH Inc.<br />Start Date: 2016-08-03<br />Medical condition: Relapsing Multiple Sclerosis (RMS)/Primary Progressive Multiple Sclerosis (PPMS)<br />Disease: <br />Version: 20.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10028245<br />Term: Multiple sclerosis<br />Level: PT<br />Version: 21.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063399<br />Term: Relapsing-remitting multiple sclerosis<br />Level: PT<br />Version: 21.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063401<br />Term: Primary progressive multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004616-37/SE\">SE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004616-37/DE\">DE</a> (Completed)</p>",
            "published_date": null,
            "discovery_date": "2023-06-05T09:00:45Z",
            "link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number%3A2015-004616-37",
            "source": "European Clinical Trials Register",
            "relevant": null,
            "identifiers": {
                "nct": null,
                "euct": "2015-004616-37",
                "eudract": "2015-004616-37"
            },
            "categories": [
                {
                    "category_id": 8,
                    "category_description": "",
                    "category_name": "Ocrelizumab",
                    "category_slug": "ocrelizumab",
                    "category_terms": [
                        "ocrelizumab",
                        "ocrevus"
                    ]
                }
            ]
        },
        {
            "trial_id": 536707,
            "title": "Investigation of the Effects of Local Vibration Applied to Different Regions and Spinal Stabilization Exercises",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Ataxia<br /><b>Interventions</b>:    Device: paraspinal vibration;   Device: gastrosoleus muscle complex vibration;   Other: Control Exercise<br /><b>Sponsor</b>:    Hacettepe University<br /><b>Enrolling by invitation</b>",
            "published_date": "2023-06-01T16:00:00Z",
            "discovery_date": "2023-06-01T13:20:47.096553Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05885282?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null,
            "identifiers": {
                "nct": "NCT05885282",
                "euct": null,
                "eudract": null
            },
            "categories": []
        },
        {
            "trial_id": 536280,
            "title": "Anti-inflammatory Diet Consultation for Those With Neuromuscular Disability",
            "summary": "<b>Conditions</b>:    Inflammation;   Spinal Cord Injuries;   Multiple Sclerosis;   Muscular Dystrophies;   Diet Habit<br /><b>Intervention</b>:    Behavioral: Mad Dog Dietary Consultation<br /><b>Sponsor</b>:    Brock University<br /><b>Completed</b>",
            "published_date": "2023-05-31T16:00:00Z",
            "discovery_date": "2023-05-31T14:20:33.991777Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05881122?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null,
            "identifiers": {
                "nct": "NCT05881122",
                "euct": null,
                "eudract": null
            },
            "categories": []
        },
        {
            "trial_id": 536279,
            "title": "Study to Evaluate the Maintenance of Efficacy When Transitioning From Anti-CD20 Therapy to Ublituximab (ENHANCE)",
            "summary": "<b>Condition</b>:    Relapsing Multiple Sclerosis<br /><b>Intervention</b>:    Biological: Ublituximab<br /><b>Sponsor</b>:    TG Therapeutics, Inc.<br /><b>Recruiting</b>",
            "published_date": "2023-05-26T16:00:00Z",
            "discovery_date": "2023-05-31T14:20:33.978062Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05877963?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null,
            "identifiers": {
                "nct": "NCT05877963",
                "euct": null,
                "eudract": null
            },
            "categories": [
                {
                    "category_id": 34,
                    "category_description": "sg",
                    "category_name": "Ublituximab",
                    "category_slug": "ublituximab",
                    "category_terms": [
                        "Ublituximab"
                    ]
                }
            ]
        },
        {
            "trial_id": 535846,
            "title": "The Effect of the Level of Hand Fatigability on Multiple Sclerosis on General Fatigue and Functionality",
            "summary": "<b>Conditions</b>:    Fatigue;   Functionality;   Multiple Sclerosis;   Dexterity<br /><b>Intervention</b>:    Diagnostic Test: Nine-Hole Peg Test (NHPT)<br /><b>Sponsor</b>:    Pamukkale University<br /><b>Completed</b>",
            "published_date": "2023-05-30T16:00:00Z",
            "discovery_date": "2023-05-30T12:40:45.850455Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05880745?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null,
            "identifiers": {
                "nct": "NCT05880745",
                "euct": null,
                "eudract": null
            },
            "categories": []
        },
        {
            "trial_id": 534031,
            "title": "The Neural Mechanisms of Split-belt Treadmill Adaptation in People With Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Interventions</b>:    Behavioral: Split-belt Treadmill;   Device: Transcutaneous Electrical Nerve Stimulation (TENS)<br /><b>Sponsors</b>:    Colorado State University;   National Multiple Sclerosis Society<br /><b>Not yet recruiting</b>",
            "published_date": "2023-05-26T16:00:00Z",
            "discovery_date": "2023-05-26T13:50:46.061145Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05878873?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null,
            "identifiers": {
                "nct": "NCT05878873",
                "euct": null,
                "eudract": null
            },
            "categories": []
        }
    ]
}